This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation pills . Kaiser Health News, an editorially independent information service, is a scheduled program of the Kaiser Family members Foundation, a nonpartisan health care policy research corporation unaffiliated with Kaiser Permanente.
And many more throughout the global world. Loss of kidney function means the majority of these individuals must undergo dialysis remedies to eliminate excess liquids and waste products. Although dialysis therapy in conjunction with medication has improved the entire life expectancy for those who have kidney failure, for unknown reasons, patients' threat of sudden heart loss of life and failure remains 10 to 20 times higher than average. Now, a report led by experts at Beth Israel Deaconess INFIRMARY and Massachusetts General Hospital helps explain why this can be the case. Today in Science Translational Medicine Appearing on-line, the new findings show that a process known as protein carbamylation contributes to cardiovascular disease risk among sufferers with kidney failing going through dialysis, and demonstrates that a blood test to measure carbamylated albumin protein might help clinicians better measure the efficiency of dialysis and identify individuals vulnerable to cardiac complications.